Urologic Neoplasms

Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

Savolitinib vs. Sunitinib in MET-driven PRCC.

Spinal Versus General Anesthesia in Open Simple Prostatectomy

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

CD70-targeted immunoPET Imaging of Kidney Cancer

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Pre-Operative Single Shot Rectus Sheath Block

Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery